版本:
中国

BRIEF-Intra-Cellular says presents data supporting potential for antidepressant activity with lumateperone

May 8 Intra-cellular Therapies Inc

* Intra-Cellular -in over 1500 individuals exposed to date in clinical trials, lumateperone has been well-tolerated with safety profile similar to placebo

* Intra-Cellular therapies inc - ongoing phase 3 lumateperone bipolar depression trials, is warranted Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐